Work Medical Technology Group LTD income statement

In fiscal 2025, Work Medical Technology Group LTD reported revenue of $9.8m, down 14.4% on the year before and net income of −$1.1m, or −$0.04 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Work Medical Technology Group LTD: income statement, annual
Fiscal year	2022Sept 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Revenue	20	14	12	10
Gross profit	4	4	3	2
Research and development	0	0	0	0
General and administrative	3	2	5	2
Interest expense	0	0	1	1
Income before tax	1	0	−4	−1
Income tax	0	0	−0	0
Net income	1	0	−3	−1
Diluted EPS	$0.07	$0.01	−$0.27	−$0.04
Diluted shares (average)	13m	13m	13m	29m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: NMTC vs WOK MLSS vs WOK NUWE vs WOK NSPR vs WOK

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Work Medical Technology Group LTD's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Work Medical Technology Group LTD.